John Bissler, MD, and his research team study a disease in children and adults called tuberous sclerosis complex (TSC), which predisposes patients to an unusual type of renal tumors. The team aims to use a newly developed model to study whether anti-hypertension drugs already approved for use in children will prevent tumors and the disease.
Dr. Bissler, a professor in the Department of Pediatrics at the University of Tennessee Health Science Center (UTHSC), has received a grant totaling $637,501 from theU.S. Army Medical Research Acquisition Activity to study renal tumor treatment options. The award will be used to support a project titled, “Prevention of TSC Renal Disease,” and will be distributed over three years. [Read more...]